Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Directorate Change

16 Sep 2013 07:03

RNS Number : 0218O
Plant Health Care PLC
16 September 2013
 



Plant Health Care PLC

 

16 September 2013

 

PLANT HEALTH CARE PLC

 

("Plant Health Care" or "the Company")

 

Directorship Changes

 

Plant Health Care appoints Dr Richard Webb as non-executive director

 

Resignation of John Brady and release from obligation to exercise options

 

The Board of Plant Health Care is pleased to announce the appointment ofRichard Webb as a non-executive director.

 

Dr Webb, age 54, has previously been engaged by the Group as a consultant, and was instrumental in the development of its new business strategy and its current research and development strategy.

 

Dr Webb is Director of StepOut Ltd, a consultancy business he founded in 1995. Prior to that, he held various posts in the former ICI, including a period managing laboratory discovery and field development programmes for its public health business. He has had particularly broad exposure to the international agrochemical industry, which he has advised across a full spectrum of activities, from research targeting to post-patent brand management.

 

Dr Webb has a personal holding of 10,000 shares in the Company (representing 0.01% of the current issued share capital).

 

Dr Christopher Richards, Chairman, commented: "Richard Webb brings many years of strategic and innovation consulting experience to the Company and will specifically reinforce the science discussions at the Board."

 

Save for the information disclosed above, there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Dr Richard Hannam Webb's appointment as a Director of the Company, other than as follows:

 

Current Directorships Past Directorships:

 

StepOut Ltd None

 

Investors in Innovation Ltd

 

Resignation of John Brady and release from obligation to exercise options

 

Further to an announcement made on 15 July 2013, the Company confirms that Mr John Brady, whose resignation as a director is effective as of today, shall be released from his obligation to exercise his options over 975,000 ordinary shares in the Company in two tranches on 15 October 2013 and13 November 2013.

 

For further information please contact:

 

Plant Health Care plc

Dr Christopher Richards, Chairman

Tel: +44 (0) 20 7250 1446

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

 

Nomura Code Securities

Dr Christopher Golden / Juliet Thompson

Tel: +44 (0) 20 7776 1200

 

Powerscourt

Nick Dibden / Sophie Moate

 

Tel: +44 (0)20 7250 1446

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABELLFXKFEBBB
Date   Source Headline
3rd Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20174:09 pmRNSGrant of options
30th Jun 20173:30 pmRNSHolding(s) in Company
15th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20174:35 pmRNSPrice Monitoring Extension
6th Jun 20177:00 amRNSNew Technology Update
31st May 20177:00 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20177:00 amRNSGrant of options
11th May 201712:50 pmRNSResult of AGM
27th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
10th Apr 20177:00 amRNSResults for the Year Ended 31 December 2016
5th Apr 20174:49 pmRNSChange of Registered Office
5th Apr 20177:00 amRNSHolding(s) in Company
5th Apr 20177:00 amRNSHolding(s) in Company
20th Feb 20177:01 amRNSDirector/PDMR Shareholding
20th Feb 20177:00 amRNSBlock listing Interim Review
8th Feb 20177:00 amRNSHolding(s) in Company
18th Jan 20177:02 amRNSResearch Update
18th Jan 20177:00 amRNSTrading Statement
19th Dec 20164:40 pmRNSSecond Price Monitoring Extn
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSBlock listing Interim Review
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.